Cargando…
Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention
OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925140/ https://www.ncbi.nlm.nih.gov/pubmed/24551110 http://dx.doi.org/10.1371/journal.pone.0088493 |
_version_ | 1782303817989095424 |
---|---|
author | Harper, Diane M. Irons, Billy B. Alexander, Natalie M. Comes, Johanna C. Smith, Melissa S. Heutinck, Melinda A. Handley, Sandra M. Ahern, Debra A. |
author_facet | Harper, Diane M. Irons, Billy B. Alexander, Natalie M. Comes, Johanna C. Smith, Melissa S. Heutinck, Melinda A. Handley, Sandra M. Ahern, Debra A. |
author_sort | Harper, Diane M. |
collection | PubMed |
description | OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years old completed a decisional satisfaction survey about their HPV vaccine experience. RESULTS: Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses. CONCLUSIONS: Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination. |
format | Online Article Text |
id | pubmed-3925140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39251402014-02-18 Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention Harper, Diane M. Irons, Billy B. Alexander, Natalie M. Comes, Johanna C. Smith, Melissa S. Heutinck, Melinda A. Handley, Sandra M. Ahern, Debra A. PLoS One Research Article OBJECTIVE: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. STUDY DESIGN: This is a prospective survey conducted at an urban college where women 18–26 years old completed a decisional satisfaction survey about their HPV vaccine experience. RESULTS: Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses. CONCLUSIONS: Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination. Public Library of Science 2014-02-14 /pmc/articles/PMC3925140/ /pubmed/24551110 http://dx.doi.org/10.1371/journal.pone.0088493 Text en © 2014 Harper et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Harper, Diane M. Irons, Billy B. Alexander, Natalie M. Comes, Johanna C. Smith, Melissa S. Heutinck, Melinda A. Handley, Sandra M. Ahern, Debra A. Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title | Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title_full | Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title_fullStr | Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title_full_unstemmed | Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title_short | Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention |
title_sort | quantifying the decisional satisfaction to accept or reject the human papillomavirus (hpv) vaccine: a preference for cervical cancer prevention |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925140/ https://www.ncbi.nlm.nih.gov/pubmed/24551110 http://dx.doi.org/10.1371/journal.pone.0088493 |
work_keys_str_mv | AT harperdianem quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT ironsbillyb quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT alexandernataliem quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT comesjohannac quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT smithmelissas quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT heutinckmelindaa quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT handleysandram quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention AT aherndebraa quantifyingthedecisionalsatisfactiontoacceptorrejectthehumanpapillomavirushpvvaccineapreferenceforcervicalcancerprevention |